- Former Merck CEO, Ken Frazier
- Former Head of FDA, Scott Gottlieb
- CRISPR Gene Therapy Patient Keynote, Victoria Gray
- Tuft's Ken Getz
- How DPHARM is tackling AI
- What to do about Protocol Complexity
- and more
In this podcast series, DPHARM Director Tracey Kimball with Valerie Bowling, Executive Director of the Conference Forum, break down what to expect at DPHARM 2025. Part I of this podcast series covers keynotes and key topics for this year's event, including:
Related Podcasts
View All
Operationalizing the Patient Voice for Long-Term Protocol Planning and Execution
How Pharma Is Adopting Generative AI Across Clinical Development
Tufts Center for Study of Drug Development on Evolving Clinical Trial Partnerships
